Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Medications for Alcohol Abuse Treatment

First-Line Medications

  • The American Association for the Study of Liver Diseases recommends naltrexone, acamprosate, and baclofen as the most effective FDA-approved medications for treating alcohol abuse, with the choice depending on liver function status and specific patient needs 1, 2, 3
  • Naltrexone reduces alcohol craving and decreases relapse rates, and its mechanism as an opioid receptor antagonist controls craving for alcohol 2
  • Acamprosate maintains rather than induces remission, and its mechanism is similar to GABA, reducing withdrawal symptoms including alcohol craving 2
  • Baclofen is the first choice for patients with alcoholic liver disease, with a standard regimen of 10 mg three times daily, and its mechanism as a GABA-B receptor agonist promotes alcohol abstinence in patients with alcoholic liver disease and cirrhosis 1, 4

Second-Line and Investigational Options

  • Topiramate is promising for reducing heavy drinking, and it decreases liver enzyme levels in treated patients 1
  • Disulfiram creates an aversive reaction when combined with alcohol, and its mechanism inhibits aldehyde dehydrogenase, causing acetaldehyde buildup 4

Management of Alcohol Withdrawal

  • Benzodiazepines are the gold standard for alcohol withdrawal syndrome, and a symptom-triggered regimen is recommended to prevent accumulation 1
  • For patients with hepatic dysfunction, short and intermediate-acting benzodiazepines like lorazepam or oxazepam are safer 1, 5
  • Thiamine supplementation is essential during withdrawal, especially for malnourished patients or those with suspected Wernicke's encephalopathy 3, 5

Important Clinical Considerations

  • Abstinence is the most important therapeutic intervention for all patients with alcohol-related liver disease 2
  • All pharmacological treatments should be combined with psychosocial support and counseling for optimal outcomes 1, 4
  • Monitoring with the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) helps guide treatment intensity 1, 5